A Special Note Regarding ALCLBreast
November 27, 2018
This week the FDA released a statement regarding a possible link between a very rare type of cancer (Anaplastic Large Cell Lymphoma) and breast implants. ALCL is typically associated with the use of certain types of textured implants and has occurred in less than 0.1% of patients that have breast implants. The majority of the breast implants used at the Centre for Plastic Surgery are NOT the type of implants associated with this type of cancer. As always, our first priority is your care and safety. Any patient with questions or concerns should contact us immediately. These FDA findings only reinforce the need for continued care and follow up with your physician. Typical warning signs of ALCL include a new onset of pain and severe swelling without injury 12 or more months after your breast implant surgery. The FDA does not recommend the removal breast implants in patients without symptoms or abnormalities. For more information click here for the FDA question and answer statement or contact us here or call 616.454.1256.
*Originally published to gr-cps.com March 23, 2017